Social phobia (SP) Mental and Behavioural Disorders
Conditions
Interventions
82 patients with social phobia diagnosis will be randomly distributed into two treatment groups: virtual exhibition or live exposure. Therapists with expertise in cognitive behavioral therapy will be
Sponsors
Anxiety Program at the Institute of Psychiatry Faculty of Medicine University of São Paulo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients: 1. Treated at the Psychotherapy Service and Anxiety Program (AMBAN) 2. Aged 18 - 65 3. Can read and write 4. Diagnosised with FS , according to the DSM -5
Exclusion criteria
Exclusion criteria: Patients: 1. With severe major depression 2. At risk for suicide, substance abuse or dependence psychotic disorders 3. Who are in psychotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy will be assessed by: 1. Down 25% to 50% in the LSAS scores will be considered partial response, and above 50% remission 2. Clinical Global Impression presenting scores 0 or 1 on the subscales of severity and improves 3. Sheehan Disability Scale presenting scores 0-3 in each of the three subscales (Work, Social Life and Family Life) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary measures: 1. Accession shall be assessed by the number of dropouts 2. The habituation, decreased anxiety during the exposure procedure is assessed by the duration in minutes for the sessions that subjective discomfort units fall from 25% to 50% 3. The duration of therapy will be evaluated by the number of sessions required for habituation to occur 4. Depressive symptoms will be assessed by the Beck Depression Inventory for (BDI) considering improves a lower score than 10 5. Improved quality of life will be assessed by Scale Social-EAS Adequacy (Weissman and Bothwell, 1976) 6. Customer satisfaction with treatment will be evaluated by CSQ-8 7. The therapeutic alliance (bond) will be evaluated by WAI | — |
Countries
Brazil
Outcome results
None listed